Total Payments
$13,109
2024 Payments
$313.40
Companies
52
Transactions
843
Medicare Patients
5,246
Medicare Billing
$413,891
Payment Breakdown by Category
Food & Beverage$12,608 (96.2%)
Consulting$325.00 (2.5%)
Education$176.02 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,608 | 835 | 96.2% |
| Consulting Fee | $325.00 | 2 | 2.5% |
| Education | $176.02 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,736 | 131 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,907 | 120 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,838 | 200 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $787.59 | 65 | $0 (2020) |
| Mylan Specialty L.P. | $400.97 | 27 | $0 (2023) |
| Grifols USA, LLC | $398.70 | 24 | $0 (2023) |
| Harmony Biosciences LLC | $357.57 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $352.94 | 22 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $350.81 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $330.79 | 35 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.40 | 3 | Noah Medical Corporation ($167.11) |
| 2023 | $2,161 | 94 | AstraZeneca Pharmaceuticals LP ($501.99) |
| 2022 | $1,324 | 92 | AstraZeneca Pharmaceuticals LP ($362.14) |
| 2021 | $1,410 | 95 | AstraZeneca Pharmaceuticals LP ($297.95) |
| 2020 | $1,681 | 105 | AstraZeneca Pharmaceuticals LP ($335.30) |
| 2019 | $2,217 | 157 | AstraZeneca Pharmaceuticals LP ($483.01) |
| 2018 | $2,140 | 152 | AstraZeneca Pharmaceuticals LP ($483.65) |
| 2017 | $1,863 | 145 | GlaxoSmithKline, LLC. ($338.98) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $127.83 | General |
| Category: RAPID DIAGNOSTICS | ||||||
| 11/08/2024 | Noah Medical Corporation | GALAXY (Device) | Food and Beverage | Cash or cash equivalent | $167.11 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 01/03/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/19/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: Neurology | ||||||
| 12/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Respiratory | ||||||
| 12/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Neurology | ||||||
| 12/11/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Respiratory | ||||||
| 12/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2023 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/10/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Airway Clearance Device | ||||||
| 11/08/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Respiratory | ||||||
| 11/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Immunology | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Respiratory | ||||||
| 10/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 10/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Respiratory | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Airway Clearance Device | ||||||
| 10/17/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Neurology | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.67 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,236 | 1,566 | $591,752 | $90,969 |
| 2022 | 16 | 1,334 | 1,718 | $524,677 | $94,241 |
| 2021 | 17 | 1,328 | 1,995 | $668,064 | $130,334 |
| 2020 | 19 | 1,348 | 1,828 | $489,102 | $98,347 |
Total Patients
5,246
Total Services
7,107
Medicare Billing
$413,891
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 154 | $158,466 | $23,737 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 159 | 249 | $55,735 | $16,626 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 239 | 313 | $44,346 | $13,807 | 31.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 99 | 104 | $135,408 | $9,292 | 6.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 65 | $25,350 | $5,689 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 54 | 54 | $19,501 | $4,432 | 22.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 48 | 49 | $59,682 | $4,165 | 7.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 69 | $19,044 | $4,016 | 21.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 88 | 88 | $20,856 | $2,785 | 13.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $10,062 | $1,642 | 16.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $9,084 | $1,550 | 17.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 173 | 178 | $13,350 | $1,021 | 7.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 84 | 84 | $6,440 | $739.82 | 11.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $2,906 | $670.34 | 23.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 84 | 84 | $7,476 | $545.84 | 7.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 34 | 34 | $4,046 | $252.45 | 6.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 47 | 161 | $157,780 | $26,190 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 170 | 254 | $54,361 | $17,953 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 257 | 321 | $43,255 | $13,888 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 72 | 72 | $24,884 | $7,115 | 28.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 127 | $33,401 | $6,770 | 20.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 46 | 46 | $57,040 | $4,076 | 7.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 52 | $19,292 | $3,950 | 20.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 40 | 40 | $46,400 | $3,287 | 7.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $13,300 | $2,473 | 18.6% |
About Dr. Pankaj Mehta, MD
Dr. Pankaj Mehta, MD is a Critical Care Medicine healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558525154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pankaj Mehta, MD has received a total of $13,109 in payments from pharmaceutical and medical device companies, with $313.40 received in 2024. These payments were reported across 843 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($12,608).
As a Medicare-enrolled provider, Mehta has provided services to 5,246 Medicare beneficiaries, totaling 7,107 services with total Medicare billing of $413,891. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Fresno, CA
- Active Since 07/12/2008
- Last Updated 09/16/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1558525154
Products in Payments
- OFEV (Drug) $974.19
- BEVESPI AEROSPHERE (Drug) $805.33
- BREZTRI (Drug) $738.82
- NUCALA (Biological) $722.73
- TRELEGY ELLIPTA (Drug) $712.10
- STIOLTO RESPIMAT (Drug) $616.89
- LONHALA MAGNAIR (Drug) $537.97
- DUPIXENT (Biological) $488.50
- FASENRA (Drug) $451.40
- Prolastin-C Liquid (Biological) $398.70
- ELIQUIS (Drug) $359.80
- Adempas (Drug) $350.81
- FASENRA (Biological) $340.38
- Wakix (Drug) $324.50
- SYMBICORT (Drug) $257.33
- Senza (Device) $243.30
- ZERBAXA (Drug) $224.95
- ANORO (Drug) $220.07
- Yupelri (Drug) $205.67
- Arikayce (Drug) $174.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Fresno
Dr. Vijai Daniel, M.d, Mph, M.D, MPH
Critical Care Medicine — Payments: $439,189
Critical Care Medicine $439,189
Dr. Lovrdu Pyreddy, M.d, M.D
Critical Care Medicine — Payments: $13,735
Critical Care Medicine $13,735
Mr. Kuldeep Gill, M.d, M.D
Critical Care Medicine — Payments: $13,598
Critical Care Medicine $13,598
Dr. Madhava Narala, M.d, M.D
Critical Care Medicine — Payments: $1,070
Critical Care Medicine $1,070
Rachel Donaldson, Md, Ms, MD, MS
Critical Care Medicine — Payments: $623.84
Critical Care Medicine $623.84
Dr. Paul Goebel, M.d, M.D
Critical Care Medicine — Payments: $505.92
Critical Care Medicine $505.92